AUS
NZ
UK
CA
USA
IND
Featured news
Radiopharm (ASX:RAD) to host educational webinar on Pivalate platform technology
June 13, 2023 10:22 AM AEST| By Team Kalkine MediaHighlights,Radiopharm Theranostics will host an educational webinar on Pivalate on 14 June.,The webinar will shed light on the company’s encouraging pre-IND meeting with the US FDA.,The webinar will also cover the late-stage development plan for the...
Fiducian Group (ASX: FID) welcomes Kerry Skellern as director
June 09, 2023 07:04 PM AEST| By ManishaHighlights,Fiducian Group has appointed Mrs Kerry Skellern as its new director.,The company expects that she would be able to contribute positively to enhance FID’s platform administration operations and IT development programs.,ASX-listed financial...
Drill assays reveal pyrite-dominated sulphides at Cooper Metals (ASX:CPM) Ardmore South Project
June 09, 2023 03:43 PM AEST| By ManishaHighlights,Cooper Metals has received preliminary drill results from Ardmore South reverse circulation (RC) drilling campaign.,Total 13 reverse circulation drill holes were drilled for 1,745m, while 685 one-metre drill hole samples were sent for anal...
Revolver Resources (ASX: RRR) gets drill rods turning at Osprey Project
June 09, 2023 12:49 PM AEST| By ManishaHighlights,Revolver Resources is undertaking the initial 2,000m diamond drill program at Osprey Project.,DDH1 Drilling Rig 15 has been mobilised to the project site.,The campaign is likely to be completed in July.,Recently, results of a detailed anal...
Imugene (ASX: IMU) announces advancement of VAXINIA MAST trial to next IV cohorts, shares jump
June 09, 2023 10:52 AM AEST| By Ankit SethiIMU's ASX-listed shares were trading in the green zone at a price of AU$0.100, up over 7.5%, after the cohort advancement announcement.
VRX Silica (ASX:VRX) gets approval for publication of Environmental Review Document for Arrowsmith North
June 09, 2023 10:17 AM AEST| By Ankit SethiThe Department of Water and Environmental Regulation has accepted the company's Arrowsmith North Environmental Review Document for publication.
Surefire (ASX:SRN) reports maiden MRE of 38Mt aluminium oxide at Victory Bore
June 08, 2023 02:19 PM AEST| By Ankit SethiThis estimation marks an uptick in the value of the project situated near the Geraldton port.
Raiden Resources (ASX:RDN / DAX:YM4) closes non-renounceable entitlement offer
June 08, 2023 01:55 PM AEST| By ManishaHighlights,Raiden Resources closed a non-renounceable entitlement issue on 1 June 2023, pursuant to its prospectus dated 11 April 2023.,The offer allowed shareholders to subscribe for one fully paid ordinary share for every four fully paid ordinary s...
First Au (ASX: FAU) reports extensive near surface gold bearing system at Haunted Stream, shares jump
June 08, 2023 10:50 AM AEST| By Ankit SethiDrilling activity is ongoing at the Haunted Stream Project, targeting the down-plunge extent of the system.
FYI Resources (ASX:FYI) appoints Head of Commercial to rev up HPA project
June 07, 2023 02:05 PM AEST| By ManishaFYI Resources (ASX:FYI) has welcomed Mr Raj Kandiah onboard as the company’s Head of Commercial.,He has been appointed to drive the company’s global growth strategy and technical product marketing related to high purity alumina (HPA) project.,T...
Jindalee Resources (ASX:JRL) commences PFS on McDermitt, appoints Fluor as lead manager
June 07, 2023 10:41 AM AEST| By Ankit SethiJRL mentions that positive developments in the global industry and intense government support are boosting the prospects for the lithium sector.
Chimeric Therapeutics (ASX:CHM) presents CHM 1101 Phase 1B trial at ASCO23 in Chicago
June 06, 2023 02:51 PM AEST| By Ankit SethiThis latest phase of clinical trial by CHM progresses on the Phase 1A dose escalation trial (no dose limiting toxicities) and a formerly presented 75% disease control rate.
Surefire (ASX:SRN) says Victory Bore PFS progressing on track for November completion
June 06, 2023 02:46 PM AEST| By Ankit SethiSRN is also assessing options for processing of concentrate in offshore locations in view of attaining operating and market advantages. Offtake and offshore discussions are also underway.
Invictus Energy (ASX:IVZ) to raise AU$12.75M via placement for Mukuyu-2 well
June 06, 2023 01:59 PM AEST| By ManishaHighlights,Invictus Energy Limited (ASX:IVZ) has announced an institutional placement for a capital raise of AU$12.75 million.,The proceeds from the placement would be used for the Phase 2 exploration and appraisal campaign in Zimbabwe’s Cabora Bassa...
Viking Mines (ASX: VKA) kicks off growth-focused vanadium drill program at Canegrass
June 06, 2023 10:45 AM AEST| By Ankit SethiThe drilling activity will target extension and discovery of new high-grade mineral resources outside of the current MRE.
Here’s how EarlyBirds’ innovation and technology ecosystem assists strategic thinkers
June 05, 2023 05:06 PM AEST| By Ankit SethiStrategic thinkers like chief operating officers have been using EarlyBirds to recognise and adopt new opportunities.
Learn how EarlyBirds’ innovation ecosystem assists with adoption of nanotechnology related advances
June 05, 2023 05:00 PM AEST| By Ankit SethiThe platform is about collaboration between the source where innovation originates (the innovator) and the destination where it is deployed (large and medium organisations).
Zooming lens over Empire Resources’ (ASX: ERL) advances on gold and copper assets
June 05, 2023 02:19 PM AEST| By ManishaHighlights,Empire Resources is focused on exploring its highly prospective gold and copper projects.,The Penny’s Gold Project has mineralisation interpreted to be similar to that at the neighbouring Garibaldi Deposit and Penny’s Find Gold Mine.,The Y...
Cooper Metals (ASX: CPM) completes RC drilling at Ardmore South, results likely in June
June 05, 2023 11:54 AM AEST| By Ankit SethiCooper Metals (ASX: CPM) has announced the successful completion of drilling campaign at Ardmore South. 13 RC holes were drilled at the site.
Chimeric Therapeutics (ASX:CHM) launches Phase 1B clinical trial in glioblastoma
June 05, 2023 10:45 AM AEST| By Ankit SethiThe multi-centre trial (conducted under a US IND) of the cell therapy will evaluate the safety and efficacy of CHM 1101.
Advertise your brand on Kalkine Media